Matches in Wikidata for { <http://www.wikidata.org/entity/Q87932058> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q87932058 description "clinical trial" @default.
- Q87932058 description "ensayu clínicu" @default.
- Q87932058 description "klinisch onderzoek" @default.
- Q87932058 description "клінічне випробування" @default.
- Q87932058 description "կլինիկական փորձարկում" @default.
- Q87932058 name "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)" @default.
- Q87932058 name "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)" @default.
- Q87932058 type Item @default.
- Q87932058 label "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)" @default.
- Q87932058 label "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)" @default.
- Q87932058 prefLabel "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)" @default.
- Q87932058 prefLabel "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)" @default.
- Q87932058 P1050 Q87932058-91EA0C66-6788-4033-A338-4D86B82A2A23 @default.
- Q87932058 P1050 Q87932058-A69E9D2F-C6B3-4840-9D07-2773921F56D8 @default.
- Q87932058 P1132 Q87932058-9441392C-29F9-4A60-8CB6-562BC80F4C6F @default.
- Q87932058 P1476 Q87932058-ADDBA410-D995-407C-8FF9-C8F73227E7B7 @default.
- Q87932058 P2899 Q87932058-0CEFE536-81CB-4BDE-9764-B578DFB6B898 @default.
- Q87932058 P3098 Q87932058-FDFF9511-D358-4883-865D-82F3FBCA3C17 @default.
- Q87932058 P31 Q87932058-6115446C-D1BF-4A33-92B7-9A30397CA9FA @default.
- Q87932058 P4844 Q87932058-07C1033F-F213-4BB6-8698-672F68E1084D @default.
- Q87932058 P4844 Q87932058-22125F7C-973B-4F73-A6C6-0F9E3D6A98B7 @default.
- Q87932058 P4844 Q87932058-27CEF044-8DCB-419F-A8C5-061D9047C60C @default.
- Q87932058 P4844 Q87932058-5C294E02-002A-4D2F-8F09-BB298F69727E @default.
- Q87932058 P4844 Q87932058-68811141-2125-46B4-8D2D-7EFA15AAB133 @default.
- Q87932058 P4844 Q87932058-E0C1EDDB-0A5D-45CD-9CC9-7BE9AF796B65 @default.
- Q87932058 P4844 Q87932058-E78AD91F-56A8-4BC4-B5BF-2B074816E675 @default.
- Q87932058 P4844 Q87932058-EDB8E583-8E64-476D-8BB9-B4F7303F189D @default.
- Q87932058 P4844 Q87932058-F52551D7-3B00-407D-89D2-4ACA3A40B4CC @default.
- Q87932058 P580 Q87932058-FF1C5DDE-11F7-44FE-A5B3-004EA45D0E86 @default.
- Q87932058 P582 Q87932058-D17F8636-6E7E-4F5F-ADA9-BEDD3B01E8D8 @default.
- Q87932058 P6099 Q87932058-3D7AB023-C54C-404F-9AC6-9BBE03C80FCD @default.
- Q87932058 P8363 Q87932058-93FCC3E0-BA2B-4CEB-8239-CBB3CD1826DE @default.
- Q87932058 P859 Q87932058-BA76BC0C-9C64-414F-94EC-C81E65327B0C @default.
- Q87932058 P1050 Q208414 @default.
- Q87932058 P1050 Q29496 @default.
- Q87932058 P1132 "+30" @default.
- Q87932058 P1476 "A Phase 1 Study of Lenalidomide in Combination With EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL)" @default.
- Q87932058 P2899 "+18" @default.
- Q87932058 P3098 "NCT04301076" @default.
- Q87932058 P31 Q30612 @default.
- Q87932058 P4844 Q18936 @default.
- Q87932058 P4844 Q27260984 @default.
- Q87932058 P4844 Q29004943 @default.
- Q87932058 P4844 Q408524 @default.
- Q87932058 P4844 Q408977 @default.
- Q87932058 P4844 Q418817 @default.
- Q87932058 P4844 Q423185 @default.
- Q87932058 P4844 Q424972 @default.
- Q87932058 P4844 Q425681 @default.
- Q87932058 P580 "2020-04-17T00:00:00Z" @default.
- Q87932058 P582 "2022-01-01T00:00:00Z" @default.
- Q87932058 P6099 Q5452194 @default.
- Q87932058 P8363 Q78089383 @default.
- Q87932058 P859 Q664846 @default.